期刊文献+

替奈替普酶诱导兔玻璃体后脱离的实验研究

An experimental study on tenecteplase-induced posterior vitreous detachment in rabbits
下载PDF
导出
摘要 目的研究玻璃体内替奈替普酶诱发玻璃体后脱离(posterior vitreous detachment,PVD)的效果及安全性。方法 30只灰兔分为A、B、C3组,每组10只。TNK-TPA100mg/L,150mg/L,250mg/L,分别注入3组兔的左眼作为实验组,0.1ml平衡盐溶液(BSS)分别注入右眼作为对照组。实验后分别观察1h、1d、3d的情况。扫描电镜、眼底检查、超声用于PVD观察,透射电镜和视网膜电图用于药物安全性判断。结果眼底和超声波检查发现实验A、B、C3组PVD发生率分别为20%、40%、90%,总发生率为50%,对照组无PVD发生,差异有统计学意义(P<0.01)。扫描和透射电镜显示实验C组发生完全性PVD,实验A和B组内界膜表面有玻璃体胶原残留。透射电镜和光镜检查发现各实验组的视网膜组织细胞未见异常,用药前后的视网膜电图差异无统计学意义(P>0.05)。结论 TNK-TPA能诱发人工PVD,250mg/L在兔眼能安全和有效地诱发完全性PVD。 Objective To investigate the efficiency and safety of tenecteplase in inducing posterior vitreous detachment(PVD)in the eyes of rabbits.Methods Thirty pigmented rabbits were randomly divided into 3 groups(group A,B,C),which received respectively 100 mg/L,150 mg/L,250 mg/L TNK-TPA in 1eft eye.The right eyes were injected with 0.1ml BSS as controls.1 hour,1 day and 3 days after the operation,PVD was evaluate by biomicroscopy,ultrasonography,scanning electron microscopy respectively.The safety was evaluated by transmission electron,light microscopy and electroretinogram.Results In group A,B,C,the incidence of PVD was 20%,40%,90% respectively according to biomicroscopy and ultrasonography examination.In experimental group,the total incidence of PVD was 50%.However PVD didn't occur in control group(P〈0.01).The complete PVD was observed in group C that received 250 mg/L TNK-TPA under scanning and transmission electron microscopy.The collagen fiber staining on the inner limiting membrane was observed in group A and group B.In all experimental groups,safety was proved by the direct observation,microscopy and electroretinogram examination(P〉0.05).Conclusion The intravitreal injection of TNK-TPA at dose of 250 mg/L can effectively and safely induce complete PVD in rabbits.
出处 《河北医药》 CAS 2010年第19期2640-2642,共3页 Hebei Medical Journal
关键词 替奈替普酶 玻璃体腔注射 玻璃体脱离 tenecteplase intravitreal injection posterior vitreous detachment
  • 相关文献

参考文献15

二级参考文献39

  • 1魏岗之,柏华.脑梗死溶栓治疗的临床与基础探索[J].中华神经科杂志,2005,38(4):279-280. 被引量:29
  • 2张志红,陶海,吴海洋.酶辅助的玻璃体切割手术研究进展[J].中华眼底病杂志,2006,22(5):352-355. 被引量:5
  • 3Alireza Z,Hossein E,Ward S C,et al.The open-artery hypothesis revisited[J].Open Artery Revisited,2006,33 (3):345-352.
  • 4Michael D H,Alastair M B.Thrombolysis for acute ischemic stroke:results of the canadian alteplase for stroke effectiveness study[J].CMAJ,2005,172 (10):1307-1312.
  • 5Daniel G C,Cleveland O H.New developments in arterial thrombolysis[J].Vascular Surgery and Interventional Radiology,2005,51-53.
  • 6Thomas K N,Christoph B.Thrombolysis:Newer Thrombolysic Agents and Their Role in Clinical Medicine[J].Heart,2003,89:1358-1362.
  • 7Menyar A A,Altamimi O M,Gomaa M M.The effect of high plasma levels of angiotensin-converting enzyme (ACE) and plasminogen activator inhibitor(PAI-1) on the reperfusion after thrombolytic therapy in patients presented with acute myocardial infarction[J].J Thromb Thrombolysis,2006,21 (3):235-240.
  • 8Clarke E H,Patrick D L,Karen C J,et al.A pilot dose-escalation safety study of tenecteplase in acute ischemic stroke[J].Stroke,2005,36:607-612.
  • 9Bruce F,Barbara F C.Thrombus formation in vivo[J].J Clin Invest,2005,115(12):3355-3362.
  • 10Chase D,Roderick P,Cooper K,et al.Using simulation to estimate the cost effectiveness of improving ambulance and thrombolysis response times after myocardial infarction[J].Emerg Med J,2006,23:67-72.

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部